Shishuo Sun

cellular therapeutics school of medicine

H指数:14

被引数:641

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2

更正：新型重组蛋白PK5-Gal-3C通过结合TRPV2增强T细胞的抗肿瘤活性

Cancer Immunology Immunotherapy

IF5.1

2026-08-190

Enhancing CAR-T Cell Efficacy in Solid Tumors by Inhibiting CCL5/VEGF-Mediated Angiogenesis

通过抑制CCL5/VEGF介导的血管生成增强CAR-T细胞在实体瘤中的疗效

Advanced Science

IF14.1

2026-05-060

Attenuated Bacteria-Based Tumor Therapy: Clinical Application Risks, Marketing Approval Restrictions, and Coping Strategies

基于减毒细菌的肿瘤疗法：临床应用风险、市场审批限制及应对策略

Advanced Science

IF14.1

2026-02-160

OAAI

HVEM costimulatory domain boosts CAR T cell efficacy against solid tumors via enhanced TRAF-mediated TNF signaling

HVEM 协同刺激域通过增强 TRAF 介导的 TNF 信号通路，提升 CAR T 细胞对实体瘤的疗效。

Cell Communication and Signaling

IF8.9

2026-01-080

OAAI

Emerging roles of EGFL family members in neoplastic diseases: Molecular mechanisms and targeted therapies

BIOCHEMICAL PHARMACOLOGY

IF5.6

2025-06-010

PRE

Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy

共刺激结构域促进car-t细胞抗肿瘤效应的分子机制

BIOCHEMICAL PHARMACOLOGY

IF5.6

2024-09-012

PRE

Tumor angiogenesis and anti-angiogenic therapy

CHINESE MEDICAL JOURNAL

IF7.3

2024-07-250

OAAI

PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca2+flux

PA通过Akt/mTOR介导的Ca2通量干扰线粒体活性来抑制T细胞的抗肿瘤免疫

CANCER LETTERS

IF10.1

2024-01-011

PRE

Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity (vol 23, 154, 2023)

BMC CANCER

IF3.4

2023-04-190

OAAI

Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity

BMC CANCER

IF3.4

2023-02-152

OAAI

Roux-en-Y reconstruction alleviates radical gastrectomy-induced colitis via down-regulation of the butyrate/NLRP3 signaling pathway

EBIOMEDICINE

IF10.8

2022-12-0118

OAAI

CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization

CD36通过促进巨噬细胞M1极化调节LPS诱导的急性肺损伤

CELLULAR IMMUNOLOGY

IF2.9

2022-02-0129

PRE

Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis

CANCER LETTERS

IF10.1

2021-12-0170

OAAI

Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancer

PHARMACOLOGICAL RESEARCH

IF10.5

2021-12-0128

PRE

Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity

酪氨酸激酶抑制剂卡博替尼通过激活固有免疫和适应性免疫抑制小鼠肾癌

FRONTIERS IN ONCOLOGY

IF3.3

2021-04-1912

OAAI

Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer

EBIOMEDICINE

IF10.8

2019-03-0156

OAAI

Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2018-02-0124

OAAI

Major role of adipocyte prostaglandin E2 in lipolysis-induced macrophage recruitment

JOURNAL OF LIPID RESEARCH

IF4.1

2016-04-0159

OAAI

Shishuo Sun

个人简介

教育背景

工作经历

荣誉奖项

研究方向